Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,303.05
|
|
Change (%)
|
-28.05 (-2.11%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,295.25
-
1,339.75
|
|
52-Week Range (RS)
|
673.10
-
1,617.80
|
|
Beta (1 Year)
|
0.39
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Other General Purpose |
| Caplin Point rises on USFDA nod for eye drops |
| Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3% |
| Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Press Release |
| Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Press Release |
| Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Loss of Share Certificates |
| Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Other General Purpose |
| Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Disclosure under SEBI Takeover Regulations |
| Anand Rathi Wealth Ltd leads losers in 'A' group |
| Caplin Point Laboratories Ltd - Caplin Point Laboratories Limited - Updates |
|
|
|
| Incoporation Year : 1990 |
| Chairman : C C Paarthipan |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Caplin Point Laboratories Ltd
Ashvich Towers 3rd Floor,
No 3 Developed Plots Ind Estat,
Chennai,
Tamil Nadu-600096 |
Phone:91-44-24968000/71148000/28156653
Fax:91-44-28154952 |
| E-Mail : investor@caplinpoint.net; info@caplinpoint.net |
| URL : http://www.caplinpoint.net |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
25-Apr-2024 |
1357.00 |
-1.91 |
| 1Month |
02-Apr-2024 |
1312.60 |
1.41 |
| 3Month |
02-Feb-2024 |
1399.25 |
-4.87 |
| 6Month |
02-Nov-2023 |
1008.50 |
31.99 |
| 1Year |
02-May-2023 |
683.20 |
94.83 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| UTI-Small Cap Fund |
1.08 |
38.25 |
| UTI-Aggressive Hybrid Fund |
0.48 |
25.61 |
| UTI-Large & Mid Cap Fund |
0.49 |
13.58 |
| UTI-Healthcare Fund |
1.39 |
13.15 |
| UTI-Retirement Fund |
0.25 |
10.79 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
2,732.60 |
2.20 |
2,745.55 |
1,599.00 |
90,489.48 |
| Gland Pharma Ltd |
1,688.55 |
-1.88 |
2,195.75 |
861.50 |
28,345.03 |
| Ajanta Pharma Ltd |
2,377.00 |
6.44 |
2,355.05 |
1,240.55 |
28,118.45 |
| ERIS Lifesciences Ltd |
867.05 |
-2.68 |
971.00 |
605.20 |
12,120.47 |
| Marksans Pharma Ltd |
165.80 |
-1.04 |
185.40 |
70.20 |
7,592.76 |
|
|
|
|